Personal care company Nu Skin (NYSE:NUS) reported Q4 CY2024 results topping the market’s revenue expectations , but sales fell by 8.8% year on year to $445.6 million. On the other hand, ...
Nu Skin stock is down 6.8% year-to-date. For updates and corrections, email newsroom[at]stocktwits[dot]com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback